Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Olympus ( (JP:7733) ) has issued an announcement.
Olympus Corporation reported a decline in its consolidated financial results for the six months ending September 30, 2025, with a notable decrease in revenue, operating profit, and profit attributable to owners. The company’s financial position remains stable with a slight decrease in total assets and equity. The orthopedic business has been classified as a discontinued operation, impacting the financial figures. Despite the downturn, Olympus maintains its forecast for the fiscal year ending March 31, 2026, indicating confidence in future performance.
The most recent analyst rating on (JP:7733) stock is a Buy with a Yen2088.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation operates in the medical technology industry, focusing on products and services related to precision machinery and instruments. The company is listed on the Prime Market of the Tokyo Stock Exchange and is known for its innovative solutions in medical, scientific, and industrial fields.
Average Trading Volume: 4,272,655
Technical Sentiment Signal: Sell
Current Market Cap: Yen2087.7B
Learn more about 7733 stock on TipRanks’ Stock Analysis page.